You are here

  • Home
  • Archive
  • Volume 12, Issue 3
  • Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial

 

Online download statistics by month:

Online download statistics by month: March 2024 to September 2025

AbstractFullPdf
Mar 2024521525170
Apr 202411671178266
May 202431431597
Jun 202414915189
Jul 2024153156146
Aug 2024919368
Sep 202410010066
Oct 202411211875
Nov 2024143145114
Dec 202413814181
Jan 202515715877
Feb 2025333335107
Mar 202513413597
Apr 202516416487
May 202512713188
Jun 2025686850
Jul 2025110
Aug 2025110
Sep 2025550
Total387839201678